A pilot study on cost-related medication nonadherence in Ontario

Journal of Population Therapeutics and Clinical Pharmacology

Volumn 19, Issue 2, 2012, Pages

  Zheng, Bo ^a   Poulose, Alice ^b   Fulford, Martha ^a   Holbrook, Anne ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b Hamilton Community Health Center   (Canada)

Author keywords

Adherence; Internal medicine clinic; Ontario; Prescription medication costs; Survey

Indexed keywords

ADULT; ARTICLE; CANADA; FEMALE; HEALTH CARE COST; HEALTH INSURANCE; HEALTH LITERACY; HEALTH STATUS; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT ATTITUDE; PILOT STUDY; PRESCRIPTION; PREVALENCE; QUESTIONNAIRE; SENSITIVITY AND SPECIFICITY; SOCIAL STATUS; TREATMENT REFUSAL; AGED; AMBULATORY CARE; DRUG COST; ECONOMICS; INSURANCE; MIDDLE AGED; PATIENT COMPLIANCE; SOCIOECONOMICS; STATISTICS; TEACHING HOSPITAL; URBAN POPULATION;

PRESCRIPTION DRUG;

ADULT; AGED; AGED, 80 AND OVER; AMBULATORY CARE; DRUG COSTS; FEMALE; HEALTH LITERACY; HEALTH STATUS; HOSPITALS, TEACHING; HUMANS; INSURANCE COVERAGE; INSURANCE, PHARMACEUTICAL SERVICES; MALE; MEDICATION ADHERENCE; MIDDLE AGED; ONTARIO; PILOT PROJECTS; PRESCRIPTION DRUGS; QUESTIONNAIRES; SOCIOECONOMIC FACTORS; TREATMENT REFUSAL; URBAN POPULATION; YOUNG ADULT;

EID: 84868337756     PISSN: 17106222     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Piette JD, Heisler M, Robert H, Alexander C. A conceptually based approach to understanding chronically ill patients' responses to medication cost pressures. Social Science & Medicine 2006;62:846-57.
2. Kennedy J, Morgan S. Cost-related prescription nonadherence in the United States and Canada: A system-level comparison using the 2007 International Health Policy Survey in seven countries. Clinical Therapeutics 2009;31(1):213-9.
3. Kirking DM, Lee JA, Ellis JJ, Briesacher B, Mckercher PL. Patient-reported underuse of prescription medications: A comparison of nine surveys. Medical Care Research and Review 2006;63:427-46.
4. Piette JD, Heisler M, Wagner TH. Cost-related medication underuse among chronically ill adults: The treatments people forgo, how often, and who is at risk. American Journal of Public Health 2004;94(10):1782-7.
5. Simpson SH, Eurich DT, Majumdar SR, et al. A meta-analysis of the association between adherence to drug therapy and mortality. British Medical Journal 2006;333:15-20.
6. Heisler M, Choi H, Rosen AB, et al. Hospitalizations and deaths among adults with cardiovascular disease who underuse medications because of cost. Medical Care 2010;48(2):87-94.
7. Osterberg L, Blaschke T. Adherence to medication. The New England Journal of Medicine 2005;353(5):487-97.
8. Schoen C, Collins SR, Kriss JL, Doty MM. How many are underinsured? Trends among U.S. adults, 2003 and 2007. Health Affairs 2008;27(4):w298-w309.
9. Rovere M. Prescription drug spending in the United States and Canada. Fraser Forum 2010;July/August:26-8.
10. Ontario Ministry of Health and Long-Term Care. Ontario Public Drug Programs. (March 31, 2010) http://www.health.gov.on.ca/english/providers/program/drugs/funded_drug/funded_drug.html (September 10, 2010).
11. Kapur V, Basu K. Drug coverage in Canada: who is at risk? Health Policy 2005;71:181-93.
12. Morrison A, MacKinnon NJ, Hartnell NR, McCaffrey KJ. Impact of drug plan management policies in Canada: A systematic review. Canadian Pharmacy Journal 2008;141:332-8.
13. Demers V, Melo M, Jackevicius C, et al. Comparison of provincial prescription drug plans and the impact on patients' annual drug expenditures. Canadian Medical Association Journal 2008;178(4):405-9.
14. Law MR, Cheng L, Dhalla IA, Heard D, Morgan SG. The effect of cost on adherence to prescription medications in Canada. CMAJ 2012;84(3):297-302.
15. Briesacher BA, Gurwitz JH, Soumerai SB. Patients at-risk for cost-related medication nonadherence: A review of the literature. Society of General Internal Medicine 2007;22:864-71.
16. Keller DL, Wright J, Pace HA. Impact of health literacy on health outcomes in ambulatory care patients: A systematic review. The Annals of Pharmacotherapy 2008;42:1272-81.
17. Lipscombe LL, Austin PC, Manuel DG, Shah BR, Hux JE, Booth GL. Income-related differences in mortality among people with diabetes mellitus. Canadian Medical Association Journal 2010;182(1):E1-17.
18. Modi AC, Rausch JR, Glauser TA. Patterns of nonadherence to antiepileptic drug therapy in children with newly diagnosed epilepsy. Journal of the American Medical Association 2011;305(16):1669-76.
19. Lexchin J, Grootendorst P. Effects of Prescription drug user fees on drug and health services use and on health status in vulnerable populations: A systematic review of the evidence. International Journal of Health Services 2004;34(1):101-22.
20. Canadian Institute for Health Information. National Health Expenditure Trends, 1975-2009. Ottawa, Ont.: CIHI, 2009.
21. Pharmaceutical Policy Research Collaboration. (2011) http://www.pharmaceuticalpolicy.ca/ (November 10 2011).
22. The NHS Information Centre for Health and Social Care. Health Survey of England 2007 Volume 2 Methodology and Documentation. London: NHS, 2007.
23. Powers BJ, Trinh JV, Bosworth HB. Can this patient read and understand written health information? Journal of the American Medical Association 2010;304(1):76-84.
24. Moisan J, Gaudet M, Gregoire JP, Bouchard R. Non-compliance with drug treatment and reading difficulties with regard to prescription labelling among seniors. Gerontology 2002;48:44-51.
25. Brooke P, Bullock R. Validation of a 6 item cognitive impairment test with a view to primary care usage. International Journal of Geriatric Psychiatry 1999;14:936-40.
26. Bebbington PE. The content and context of compliance. International Clinical Psychopharmacology 1995;9(S5):41-50.
27. Gusdal AK, Obua C, Andualem T, et al. Voices on adherence to ART in Ethiopia and Uganda: A matter of choice or simply not an option? AIDS Care 2009;21(11):1381-7.
28. Gebremariam MK, Bjune GA, Frich JC. Barriers and facilitators of adherence to TB treatment in patients on concomitant TB and HIV treatment: a qualitative study. BMC Public Health 2010;10:651.
29. Schafheutle E, Hassell K, Noyce PR. Coping with prescription charges in the UK. International Journal of Pharmacy Practice 2004;12:239-46.
30. Allan GM, Lexchin J, Wiebe N. Physician awareness of drug cost: A systematic review. PLoS Med 2007;4(9):e283.
31. Patel MR, Coffman JM, Tseng CW, Clark NM, Cabana MD. Physician communication regarding cost when prescribing asthma medication to children. Clinical Pediatrics 2009;48(5):493-8.
32. Brask-Lindemann D, Cadarette SM, Eskildsen P, Abrahamsen B. Osteoporosis pharmacotherapy following bone densitometry: Importance of patient beliefs and understanding of DXA results. 2011;22(5):1493-501.
33. Gellad WF, Huskamp HA, Li A, Zhang Y, Safran DG, Donohue JM. Use of prescription drug samples and patient assistance programs, and the role of doctor-patient communication. Journal of General Internal Medicine.2011;26(12):1458-64.